MarketBeat
09 May 2026, 05:07 UTC · 20w ago
Verdict
Headline takes no side. We score TNDM +0.80 across seven claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
7 claims · scored −1 bearish … +1 bullish
Tandem Diabetes Care reaffirmed its full-year 2026 sales guidance of $1.065 billion to $1.085 billion alongside a targeted adjusted EBITDA margin of 5% to 6%.
More positive than 99% of claims this week
The PayGo pharmacy channel rollout is in its infancy with less than 5% of customers ordering through it, representing only 6% of U.S. sales and a $1 million headwind in Q1.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 98% of claims this week
Infusion set shortages caused by supplier capacity challenges are persisting into Q2 and significantly impacting affected customers.
More negative than 95% of claims this week
Tandem received FDA clearance for Control-IQ+ use in pregnant women with type 1 diabetes, making its pumps the first and only commercially available automated insulin delivery systems cleared for this demographic in the U.S.
So whatThis creates a strong competitive moat in a specific, high-value demographic that should drive new starts and capture market share from rival insulin delivery systems.
More positive than 89% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
Reported record first-quarter shipments and sales, improved gross margins, and received FDA clearance for a new indication.
More positive than 55% of ticker scores this week
Positive mention regarding the integration of its FreeStyle Libre 3 Plus with Tandem products in Europe.
More positive than 55% of ticker scores this week
Positive mention regarding upcoming compatibility upgrades between Tandem pumps and the Dexcom G7 sensor.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
52m ago
More positive than 35% of relationship scores this week
[mutual] Tandem is upgrading its t:slim and Mobi pumps for compatibility with Dexcom's G7 sensor.
+6.9%
Price agrees with the score
$16.55 vs $15.48 close before publication (May 8) · not market-adjusted
TNDM chart →
